The Cardiology Report

This edition of The Cardiology Report focuses on the mechanisms of action of warfarin and the newer oral anticoagulants; the pathophysiology and treatment of atrial fibrillation; the evidence supporting the use of oral anticoagulants in patients with atrial fibrillation, as well as deep venous thrombosis and pulmonary embolism; and the issues surrounding their use in clinical practice.

VIEW Report

RATIONALE AND PURPOSE

Since the early 1950s, long-term, warfarin-based anticoagulation has protected countless patients with atrial fibrillation from having a stroke, as well as patients at risk of deep venous thrombosis and embolism. More

TARGET AUDIENCE

Cardiologists and other physicians significantly involved in the management of atrial fibrillation and stroke prevention should find participating in this educational activity valuable.

CREDIT AVAILABILITY

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME). More

CONTACT INFORMATION

We would like to hear your comments regarding this or other educational activities produced by Direct One Communications, Inc. In addition, suggestions for future activities are welcome.